Machine Learning

A key industry report names Level AI a 'Pioneer' in both QA and analytics, highlighting the power of its integrated AI approach in a crowded tech market.

Wolters Kluwer's UpToDate again tops KLAS rankings, highlighting a major trend: integrating expert-backed patient education directly into clinical care.

The tech giant's savvy financial moves are set to save $27M annually, extending maturities and freeing up cash for future innovation and growth.

A new report reveals a major shift in cybersecurity strategy as firms abandon tool sprawl for unified control, driven by AI threats and cloud complexity.

A new report reveals a startling contradiction: while HR feels empowered, 62% admit their own outdated practices are creating a self-inflicted talent shortage.

A new partnership promises to cut AI review times from weeks to hours, aiming to unlock innovation and accelerate AI adoption in critical federal missions.

In an unprecedented move, Artlist created its Big Game ad in under five days using AI, challenging multi-million dollar productions and sparking industry debate.

Bitcoin miner CleanSpark makes a massive pivot, securing a 600MW Texas site to power the AI boom, diversifying beyond the volatile crypto market.

With 46% of developers distrusting AI code, Qodo 2.0's new multi-agent architecture aims to restore faith by delivering more accurate, context-aware reviews.

A new strategic alliance aims to solve AI's biggest enterprise challenge: balancing innovation with ironclad security for developers and autonomous agents.

A new partnership is trading vague online metrics for real-world visits, proving advertising's impact and reshaping how tourist destinations spend money.

GMMB promotes digital strategist Erica Monteith and ad maker Jodi Quintero, signaling a deep investment in data-driven innovation and powerful advocacy.

The digital health giant now offers a 50+ cancer blood test, promising early detection. But experts caution on its limits and lack of FDA approval.

New preclinical data suggests Arcellx's CAR T therapy may offer a safer profile than rivals, potentially avoiding severe neurological side effects.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

A Chinese tech firm plans to bring its automated parking solutions to NYC and LA, facing a crowded market, financial hurdles, and geopolitical scrutiny.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A top KLAS award reveals a new era in healthcare cybersecurity, where measurable risk reduction and financial value are becoming more important than ever.